References: 1. Centers for Disease Control and Prevention. Meningococcal vaccination for adolescents: Information for healthcare professionals. http://www.cdc.gov/vaccines/vpd/mening/hcp/adolescent-vaccine.html. Reviewed July 26, 2019. Accessed March 18, 2020. 2. Meningococcal disease. In: Hamborsky J, Kroger A, Wolfe S, eds. Epidemiology and Prevention of Vaccine-Preventable Diseases. 13th ed. Washington, DC: Public Health Foundation; 2015;261-278. http://www.cdc.gov/vaccines/pubs/pinkbook/mening.html. Accessed July 12, 2018. 3. Thompson MJ, Ninis N, Perera R, et al. Clinical recognition of meningococcal disease in children and adolescents. Lancet. 2006;367(9508):397-403. 4. Pelton SI. Meningococcal disease awareness: clinical and epidemiological factors affecting prevention and management in adolescents. J Adolesc Health. 2010;46:S9-S15. 5. Slack R, Hawkins KC, Gilhooley L, Addison GM, Lewis MA, Webb NJA. Long-term outcome of meningococcal sepsis-associated acute renal failure. Pediatr Crit Care Med. 2005;6(4):477-479. 6. Vyse A, Anonychuk A, Jäkel A, et al. The burden and impact of severe and long-term sequelae of meningococcal disease. Expert Rev Anti Infect Ther. 2013;11(6):597-604. 7. Cohn AC, MacNeil JR, Clark TA, et al. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2013;62(RR-2):1-28. 8. MacNeil J, Cohn A. Meningococcal disease. In: Roush SW, Baldy LM, eds. Manual for the Surveillance of Vaccine-Preventable Diseases. 6th ed. http://www.cdc.gov/vaccines/pubs/surv-manual/chpt08-mening.html. Updated April 1, 2014. Accessed July 12, 2018. 9. Meningococcal disease: causes and transmission. Centers for Disease Control and Prevention website. http://www.cdc.gov/meningococcal/about/causes-transmission.html. Updated June 11, 2015. Accessed July 12, 2018. 10. Centers for Disease Control and Prevention. Active bacterial core surveillance (ABCs). Neisseria meningitidis, 2005-2014. Centers for Disease Control and Prevention website. http://www.cdc.gov/abcs/reports-findings/surv-reports.html. Accessed July 12, 2018. 11. Meyer S. Epidemiology of meningococcal disease among college students—United States, 2014-2016. https://stacks.cdc.gov/view/cdc/59918. Presented at the Advisory Committee on Immunization Practices meeting; February 22, 2018. Accessed June 25, 2019. 12. Mayo Clinic. Meningitis. https://www.mayoclinic.org/diseases-conditions/meningitis/symptoms-causes/syc-20350508. Accessed August 7, 2019. 13. Meningococcal Disease on U.S. College Campuses, 2013-2019. National Meningitis Association. www.nmaus.org/wp-content/uploads/2019/04/Alembic_NMA_Map_r28.pdf. Updated April 2019. Accessed June 5, 2019. 14. Marshall GS, Dempsey AF, Srivastava, Isturiz RE. US college students are at increased risk for serogroup B meningococcal disease. JPIDS. 2019:1-4. 15. Enhanced Meningococcal Disease Surveillance Reports, 2015-2017. Centers for Disease Control and Prevention website. www.cdc.gov/meningococcal/surveillance/index.html#enhanced-reports. Accessed June 5, 2019. 16. Mbaeyi SA, Joseph SJ, Blain A, et al. Meningococcal Disease Among College-Aged Young Adults: 2014–2016. Pediatrics. 2019;143(1):1-8. 17. Data on file, GSK. 18. Meningococcal ACWY prevention mandates for colleges and universities. Immunization Action Coalition website. www.immunize.org/laws/menin.asp. Updated November 11, 2018. Accessed June 5, 2019.
BEXWCNT200001 March 2020